This HTML5 document contains 126 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/
n7http://dx.doi.org/10.2147/

Statements

Subject Item
wd:Q36700300
rdf:type
wikibase:Item
schema:description
artigo científico wissenschaftlicher Artikel научни чланак 2005年论文 article scientific teaduslik artikkel 2005年の論文 wetenschappelijk artikel scienca artikolo 2005년 논문 articol științific 2005年论文 artikel ilmiah מאמר מדעי জুন ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ научная статья article científic 2005年论文 bài báo khoa học 2005年論文 scientific article published on June 2005 naučni članak vědecký článek 2005年论文 artikulong pang-agham videnskabelig artikel vetenskaplig artikel наукова стаття, опублікована в червні 2005 2005年論文 2005年论文 scientific article published on June 2005 bilimsel makale vitskapeleg artikkel 2005年论文 სამეცნიერო სტატია articolo scientifico 2005年論文 научна статия tudományos cikk artigo científico мақолаи илмӣ article scientifique artykuł naukowy tieteellinen artikkeli artikull shkencor επιστημονικό άρθρο vedecký článok artículo científico publicado en 2005 vitenskapelig artikkel 2005年論文 مقالة علمية نشرت في يونيو 2005 2005年論文 2005 nî lūn-bûn научни чланак scientific article published on June 2005 artículu científicu espublizáu en 2005 บทความทางวิทยาศาสตร์ artigo científico
p:P577
wds:Q36700300-6852E4DA-0799-4A4F-A36E-248D23293C48
wdt:P577
2005-06-01T00:00:00Z
p:P407
wds:Q36700300-1BA844BC-C54F-4DA9-8521-713C2BE74B5A
wdt:P407
wd:Q1860
p:P2860
wds:Q36700300-C1740753-9A8F-4830-9F6F-27050508C6A2 wds:Q36700300-CD5B7E55-7850-4D26-998C-DA9417FB89C3 wds:Q36700300-D006571B-CE31-4A4F-A32A-DAE1BAC63E07 wds:Q36700300-F389F714-C77C-483A-A291-893F30A7AF46 wds:Q36700300-F8DDC00C-277B-4ACE-9014-773397042DD7 wds:Q36700300-7FE171CE-5A18-4B58-9F64-397F408E60B9 wds:Q36700300-9C9BE5A2-2D3B-4851-A04C-AE8592885212 wds:Q36700300-A4C479C3-CC14-4701-BAA8-C0EB3DF6284D wds:Q36700300-B9764531-133E-4E72-809E-3CFB6904195B wds:Q36700300-41B174B7-5F8A-4A8C-9BC4-F6E8B4306D0E wds:Q36700300-12BD7DD1-6758-48E5-8754-9C9E2D92FA1D wds:Q36700300-36726FB8-D667-45FA-8338-5BF04258398E
wdt:P2860
wd:Q71808806 wd:Q77639715 wd:Q44718367 wd:Q51041697 wd:Q73965153 wd:Q25938989 wd:Q28211021 wd:Q67364448 wd:Q40879741 wd:Q33927821 wd:Q74503855 wd:Q33183905
p:P2093
wds:Q36700300-48C4BF8D-8FBE-4C35-A2F6-64633F3084F9 wds:Q36700300-39432138-81A1-4DA2-893C-B46B1B76C98C wds:Q36700300-051E462D-891D-4A07-A7C9-769B3E8EC833
wdt:P2093
Kristin Brousseau Susie Harris David Arciniegas
rdfs:label
Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations
skos:prefLabel
Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations
schema:name
Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations
p:P1476
wds:Q36700300-42F4993B-7913-4744-8D6D-490795DCA4BD
wdt:P1476
Pharmacologic management of anxiety and affective lability during recovery from Guillain-Barré syndrome: some preliminary observations
p:P304
wds:Q36700300-95CEF9EA-9C5B-4593-A6FA-F65A17A1508A
wdt:P304
145-149
p:P31
wds:Q36700300-7024D389-9BDD-47BA-9CCB-1BF0C907F72D
wdt:P31
wd:Q13442814
p:P921
wds:Q36700300-C0E71E87-3A27-4B65-B1A5-69F8E10BB5D0
wdt:P921
wd:Q205214
p:P698
wds:Q36700300-47C28F31-24CA-42C6-A552-9D4909651D8E
wdtn:P698
n12:18568059
wdt:P698
18568059
p:P1433
wds:Q36700300-401F4A1C-3DF0-44C1-B231-324AB6A2F38A
wdt:P1433
wd:Q15716332
p:P433
wds:Q36700300-E2E3BDAC-152B-44C5-A700-CC7892270098
p:P478
wds:Q36700300-2B2C5B68-12CA-40FC-856E-E916987CB1B2
wdt:P433
2
wdt:P478
1
p:P356
wds:Q36700300-8CB022EE-9219-4FFF-BF0F-E4DFE7960752
wdtn:P356
n7:NEDT.1.2.145.61047
wdt:P356
10.2147/NEDT.1.2.145.61047
p:P5875
wds:Q36700300-5DD44403-1C7D-4FB9-B509-5B698E7AB008
wdt:P5875
5288643
p:P932
wds:Q36700300-0D37338A-F0FF-45EE-8416-8E346CDFAA81
wdt:P932
2413194